Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Multicentre external validation of IOTA prediction models and RMI by operators with varied training.

Sayasneh A, Wynants L, Preisler J, Kaijser J, Johnson S, Stalder C, Husicka R, Abdallah Y, Raslan F, Drought A, Smith AA, Ghaem-Maghami S, Epstein E, Van Calster B, Timmerman D, Bourne T.

Br J Cancer. 2013 Jun 25;108(12):2448-54. doi: 10.1038/bjc.2013.224.

2.

A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses.

Sayasneh A, Kaijser J, Preisler J, Johnson S, Stalder C, Husicka R, Guha S, Naji O, Abdallah Y, Raslan F, Drought A, Smith AA, Fotopoulou C, Ghaem-Maghami S, Van Calster B, Timmerman D, Bourne T.

Gynecol Oncol. 2013 Jul;130(1):140-6. doi: 10.1016/j.ygyno.2013.04.003.

PMID:
23578539
3.

Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.

Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T, Timmerman D, Van Calster B.

Hum Reprod Update. 2014 May-Jun;20(3):449-62. doi: 10.1093/humupd/dmt059. Review.

4.

Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.

Di Legge A, Testa AC, Ameye L, Van Calster B, Lissoni AA, Leone FP, Savelli L, Franchi D, Czekierdowski A, Trio D, Van Holsbeke C, Ferrazzi E, Scambia G, Timmerman D, Valentin L.

Ultrasound Obstet Gynecol. 2012 Sep;40(3):345-54. doi: 10.1002/uog.11167.

5.

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D, Savelli L, Epstein E, Czekierdowski A, Guerriero S, Fruscio R, Leone FP, Vergote I, Bourne T, Valentin L, Van Calster B, Timmerman D.

Br J Cancer. 2014 Aug 12;111(4):680-8. doi: 10.1038/bjc.2014.333.

6.

Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.

Meys EM, Kaijser J, Kruitwagen RF, Slangen BF, Van Calster B, Aertgeerts B, Verbakel JY, Timmerman D, Van Gorp T.

Eur J Cancer. 2016 May;58:17-29. doi: 10.1016/j.ejca.2016.01.007. Review.

PMID:
26922169
7.

The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.

Knafel A, Banas T, Nocun A, Wiechec M, Jach R, Ludwin A, Kabzinska-Turek M, Pietrus M, Pitynski K.

Ultraschall Med. 2016 Oct;37(5):516-523.

PMID:
26126150
8.

Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.

Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D.

Ultrasound Obstet Gynecol. 2011 Oct;38(4):456-65. doi: 10.1002/uog.9030.

9.

External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.

Van Holsbeke C, Van Calster B, Bourne T, Ajossa S, Testa AC, Guerriero S, Fruscio R, Lissoni AA, Czekierdowski A, Savelli L, Van Huffel S, Valentin L, Timmerman D.

Clin Cancer Res. 2012 Feb 1;18(3):815-25. doi: 10.1158/1078-0432.CCR-11-0879.

10.

Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.

Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I, Testa AC, Franchi D, Van Calster B, Timmerman D.

Ultrasound Obstet Gynecol. 2013 Jan;41(1):9-20. doi: 10.1002/uog.12323. Review.

11.

Clinically oriented three-step strategy for assessment of adnexal pathology.

Ameye L, Timmerman D, Valentin L, Paladini D, Zhang J, Van Holsbeke C, Lissoni AA, Savelli L, Veldman J, Testa AC, Amant F, Van Huffel S, Bourne T.

Ultrasound Obstet Gynecol. 2012 Nov;40(5):582-91. doi: 10.1002/uog.11177.

12.

A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer.

Nunes N, Ambler G, Hoo WL, Naftalin J, Foo X, Widschwendter M, Jurkovic D.

Int J Gynecol Cancer. 2013 Nov;23(9):1583-9. doi: 10.1097/IGC.0b013e3182a6171a.

PMID:
24088790
13.

Estimating the risk of malignancy in adnexal masses: an external validation of the ADNEX model and comparison with other frequently used ultrasound methods.

Meys EM, Jeelof LS, Achten NM, Slangen BF, Lambrechts S, Kruitwagen RF, Van Gorp T.

Ultrasound Obstet Gynecol. 2016 Aug 12. doi: 10.1002/uog.17225. [Epub ahead of print]

PMID:
27514486
14.

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.

Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, Van Holsbeke C, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Van Huffel S, Bourne T, Valentin L.

BMJ. 2010 Dec 14;341:c6839. doi: 10.1136/bmj.c6839.

15.

A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.

Kaijser J, Van Gorp T, Van Hoorde K, Van Holsbeke C, Sayasneh A, Vergote I, Bourne T, Timmerman D, Van Calster B.

Gynecol Oncol. 2013 May;129(2):377-83. doi: 10.1016/j.ygyno.2013.01.018.

PMID:
23360924
16.

Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.

Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, Savelli L, Vergote I, Bourne T, Van Huffel S, Valentin L.

Ultrasound Obstet Gynecol. 2010 Aug;36(2):226-34. doi: 10.1002/uog.7636.

18.

Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.

Ruiz de Gauna B, Rodriguez D, Olartecoechea B, Aubá M, Jurado M, Gómez Roig MD, Alcázar JL.

Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:10-4. doi: 10.1016/j.ejogrb.2015.05.024.

PMID:
26066289
20.

Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound.

Arun-Muthuvel V, Jaya V.

Asian Pac J Cancer Prev. 2014;15(6):2929-32.

Items per page

Supplemental Content

Support Center